Peter B. F. Bergqvist

Author

Also Known As

Not Available Not Available, P B Bergqvist, P B F Bergqvist, P. B. F. Bergqvist, P. Bergqvist, P.B.F. BERGQVIST, P.B.F. Bergqvist, Peter B. F. Bergqvist, Peter B.F Bergqvist, Peter B.F. Bergqvist

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Lund University University of Gothenburg AstraZeneca (Sweden)McGill University Stockholm University College of Music Education

About

Peter B. F. Bergqvist is an author at Lund University specializing in medicine, neuroscience, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	804
2	Social Sciences	8	8	505
3	Health Sciences	2	2	43
4	Allergy	2	2	112
5	Allergy Medicine	1	1	32

Peter B. F. Bergqvist

Publications

899

Citations

H-Index

Page 1

	Year	Citations
Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities Connie Sánchez, Peter B. F. Bergqvist, Lise T. Brennum, Psychopharmacology PsychiatryMedicinePsychotropic MedicationDepressionPsychopharmacology	2003	265
One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort® Turbuhaler®) for the treatment of asthma L Rosenhall, A. ELVSTRAND, Björn Tilling, Respiratory Medicine AsthmaPulmonary CareAllergyMedicineOne-year Safety	2003	80
Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive–compulsive disorder Peter B. F. Bergqvist, Claude Bouchard, Pierre Blier Biological Psychiatry PsychopathologyBrain RegionsPsychiatryPsychotropic MedicationDepression	1999	71
Neoadjuvant Androgen Deprivation Therapy for Prostate Volume Reduction, Lower Urinary Tract Symptom Relief and Quality of Life Improvement in Men with Intermediate- to High-risk Prostate Cancer: A Randomised Non-inferiority Trial of Degarelix versus Goserelin plus Bicalutamide Malcolm D. Mason, Xavier Maldonado, Christopher P. Steidle, Clinical Oncology UrologyOncologyHigh-risk Prostate CancerGenitourinary CancerDegarelix Versus Goserelin	2012	68
Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction H. J. van der Woude, Martin Boorsma, Peter B. F. Bergqvist, Pulmonary Pharmacology & Therapeutics AsthmaRespiratory DiseasesMedicineSingle InhalerPulmonary Pharmacology	2003	62
Effect of atypical antipsychotic drugs on 5-HT 2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study Peter B. F. Bergqvist, Jianming Dong, Pierre Blier Psychopharmacology NeuropsychologyAtypical Antipsychotic DrugsPsychoactive DrugPsychiatryNeurophysiology	1999	59
Neocortical Dialysate Monoamines of Rats After Acute, Subacute, and Chronic Liver Shunt Peter B. F. Bergqvist, Birgit A. P. M. Vogels, D. K. Bosman, Journal of Neurochemistry	1995	45
Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder Mats B. Humble, Susanne Bejerot, Peter B. F. Bergqvist, Biological Psychiatry PsychiatryAddictionPsychotropic MedicationObsessive-compulsive DisorderDrug Response	2001	32
Budesonide/formoterol (Symbicort) is well tolerated and effective in patients with moderate persistent asthma. L Rosenhall, J. H. Heinig, Ari Lindqvist, PubMed AsthmaMini Asthma QualityLife QuestionnaireAllergyModerate Persistent Asthma	2002	32
Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy. Cecilia Wikell, Peter B. F. Bergqvist, Stephan Hjorth, PubMed NeuropsychologyPsychopharmacologyPharmacotherapyExperimental PharmacologySocial Sciences	1998	29

Page 1